Dr. Metz Discusses Using a Multidisciplinary Approach When Treating NETs

David C. Metz, MBBCh
Published: Monday, Oct 13, 2014

David C. Metz, MBBCh, professor of medicine, co-director, GI Physiology laboratory, Hospital of the University of Pennsylvania, discusses using a multidisciplinary approach to treating neuroendocrine tumors (NETs).

As NETs have a tremendous spread of potential involvement across disciplines, there is significant potential to having multidisciplinary input.

Metz says the field is growing and important, however, he stresses that not every person that has a NET needs to go to a center of excellence that has a multidisciplinary approach because it is not practical. It is important to have availability across the country in various locations where there are going to be experts that get together and discuss specific patients, Metz says.

In the future, physicians may be moving towards a situation where a virtual tumor board may be available to discuss specific cases of patients in very isolated areas, Metz says.  As NETs are not particularly common, physicians are still learning.

<<< View more from NANETS 2014

David C. Metz, MBBCh, professor of medicine, co-director, GI Physiology laboratory, Hospital of the University of Pennsylvania, discusses using a multidisciplinary approach to treating neuroendocrine tumors (NETs).

As NETs have a tremendous spread of potential involvement across disciplines, there is significant potential to having multidisciplinary input.

Metz says the field is growing and important, however, he stresses that not every person that has a NET needs to go to a center of excellence that has a multidisciplinary approach because it is not practical. It is important to have availability across the country in various locations where there are going to be experts that get together and discuss specific patients, Metz says.

In the future, physicians may be moving towards a situation where a virtual tumor board may be available to discuss specific cases of patients in very isolated areas, Metz says.  As NETs are not particularly common, physicians are still learning.

<<< View more from NANETS 2014


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Publication Bottom Border
Border Publication
x